G H Dayan

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Cost-effectiveness of influenza vaccination in high-risk children in Argentina
    G H Dayan
    Fundación Centro de Estudios Infectológicos, Buenos Aires, Argentina
    Vaccine 19:4204-13. 2001
  2. ncbi Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico
    Gustavo H Dayan
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 195:12-20. 2007
  3. ncbi Efforts at rubella elimination in the United States: the impact of hemispheric rubella control
    Gustavo H Dayan
    National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 43:S158-63. 2006
  4. ncbi Assessment of delay in age-appropriate vaccination using survival analysis
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Am J Epidemiol 163:561-70. 2006
  5. ncbi Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002
    G H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Epidemiol Infect 133:861-9. 2005
  6. ncbi The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 116:e1-4. 2005
  7. ncbi Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS)
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 14:671-6. 2005
  8. ncbi Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, MS E 61, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 42:5698-704. 2004
  9. ncbi Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome
    Gustavo H Dayan
    Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 187:S235-40. 2003
  10. ncbi Cost-effectiveness of three different vaccination strategies against measles in Zambian children
    Gustavo H Dayan
    Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Vaccine 22:475-84. 2004

Detail Information

Publications22

  1. ncbi Cost-effectiveness of influenza vaccination in high-risk children in Argentina
    G H Dayan
    Fundación Centro de Estudios Infectológicos, Buenos Aires, Argentina
    Vaccine 19:4204-13. 2001
    ..our study aimed to evaluate the cost-effectiveness of influenza vaccination in high-risk children in Argentina...
  2. ncbi Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico
    Gustavo H Dayan
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 195:12-20. 2007
    ..Studies assessing inactivated poliovirus vaccine (IPV) immunogenicity in tropical countries, using the WHO Expanded Programme on Immunization (EPI) schedule, have been limited...
  3. ncbi Efforts at rubella elimination in the United States: the impact of hemispheric rubella control
    Gustavo H Dayan
    National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 43:S158-63. 2006
    ..Implementation of rubella control strategies in the Americas, particularly in Mexico, appears to have facilitated rubella elimination in the United States...
  4. ncbi Assessment of delay in age-appropriate vaccination using survival analysis
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Am J Epidemiol 163:561-70. 2006
    ..90) compared with those whose caregivers had not completed primary school. Survival analysis methods were helpful in measuring vaccine uptake and should be considered in future surveys when assessing delay in age-appropriate vaccination...
  5. ncbi Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002
    G H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Epidemiol Infect 133:861-9. 2005
    ..Our findings support the introduction of supplemental immunization activities targeting adolescents and young adults to prevent congenital rubella syndrome and measles outbreaks over time...
  6. ncbi The cost of containing one case of measles: the economic impact on the public health infrastructure--Iowa, 2004
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 116:e1-4. 2005
    ..One exposed, susceptible student returned home during his infectious period, necessitating 2 months of containment efforts in Iowa...
  7. ncbi Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS)
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 14:671-6. 2005
    ..We used data from reports to the Vaccine Adverse Event Reporting System (VAERS) to develop a proxy means of surveillance for the lifecycle of selected vaccine lots...
  8. ncbi Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, MS E 61, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 42:5698-704. 2004
    ..In Argentina, seroprevalence in women more than 15 years old was high regardless of the area of residence. Negative or uncertain varicella history was not a good predictor of immunity. VZV genotype was stable in all areas of the country...
  9. ncbi Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome
    Gustavo H Dayan
    Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 187:S235-40. 2003
    ..These findings highlight the importance of introducing rubella-containing vaccine in conjunction with measles elimination activities...
  10. ncbi Cost-effectiveness of three different vaccination strategies against measles in Zambian children
    Gustavo H Dayan
    Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Road, Mailstop E 61, Atlanta, GA 30333, USA
    Vaccine 22:475-84. 2004
    ..Given the parameters established for this analysis, such a program would be cost-saving and the most cost-effective vaccination strategy for Zambia...
  11. ncbi Assessment of areas at increased risk for poliovirus circulation in Ecuador
    Gustavo H Dayan
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Epidemiol Infect 132:787-95. 2004
    ..From the 14 environmental samples taken, we identified Sabin viruses in six of the samples; no vaccine-derived polioviruses were isolated. Using this methodology, we found no evidence of undetected poliovirus circulation in Ecuador...
  12. ncbi Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002
    Gustavo H Dayan
    Epidemiology and Survaillance Division, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Rev Panam Salud Publica 16:158-67. 2004
    ....
  13. ncbi Measles outbreak in the Republic of the Marshall Islands, 2003
    Terri B Hyde
    Viral Vaccine Preventable Diseases Branch, National Immunization Program, NIP, Centers for Disease Control and Prevention, CDC, Atlanta, GA 30333, USA
    Int J Epidemiol 35:299-306. 2006
    ..Reported 1-dose measles vaccine coverage among children aged 12-23 months varied widely (52-94%) between 1990 and 2000...
  14. ncbi Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population
    Anand A Date
    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 197:1662-8. 2008
    ..High attack rates among vaccinated young adults reported during the 2006 mumps outbreak in the United States heightened concerns regarding mumps vaccine failure...
  15. ncbi Recent resurgence of mumps in the United States
    Gustavo H Dayan
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 358:1580-9. 2008
    ..S. schoolchildren beginning in 1990 was followed by historically low reports of mumps cases. A 2010 elimination goal was established, but in 2006 the largest mumps outbreak in two decades occurred in the United States...
  16. ncbi Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage
    Rebecca H Bitsko
    Epidemic Intelligence Service, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 46:1101-3. 2008
    ..Seven of the eight reverse transcription-PCR-positive specimens were collected during the first 3 days of parotitis, suggesting that viral shedding is minimal after the first 3 days of symptoms...
  17. ncbi Medical practices for prevention of perinatal infections in Puerto Rico
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Paediatr Perinat Epidemiol 22:31-9. 2008
    ..Screening rates for rubella and hepatitis B were high; however, implementation of recommendations for prevention of rubella and hepatitis B needs to be improved...
  18. ncbi Seroprevalence of measles antibody in the US population, 1999-2004
    Geraldine M McQuillan
    Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782, USA
    J Infect Dis 196:1459-64. 2007
    ..Testing for measles antibody was included in the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey, conducted during 1999-2004...
  19. ncbi Mumps surveillance and prevention: putting mumps back on our radar screen
    Moe H Kyaw
    Cleve Clin J Med 74:13-5. 2007
  20. ncbi Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States
    Amy A Parker
    Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 355:447-55. 2006
    ..Maintenance of high rates of vaccination coverage, including improved strategies of communication with persons who refuse vaccination, is necessary to prevent future outbreaks and sustain the elimination of measles in the United States...
  21. ncbi Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina
    Michael Martin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 23:842-7. 2004
    ..Surrogate indicators of bacterial meningitis also declined and might be useful measures of Hib conjugate vaccine impact at hospitals where capacity to culture Hib is not available...
  22. ncbi Mumps vaccine performance among university students during a mumps outbreak
    Margaret M Cortese
    National Center for Immunization and Respiratory Diseases, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 46:1172-80. 2008
    ..We assessed vaccine performance and mumps risk factors, including the possibility of waning vaccine protection...